Skip to main content
Clinical Trials/NCT03205904
NCT03205904
Completed
Not Applicable

Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.

Hospital de Clinicas de Porto Alegre1 site in 1 country20 target enrollmentDecember 12, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cystic Fibrosis-related Diabetes
Sponsor
Hospital de Clinicas de Porto Alegre
Enrollment
20
Locations
1
Primary Endpoint
glycemic improvement after nutritional orientation in patients with cystic fibrosis in the pre-diabetic phase
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Cystic fibrosis (CF) is a genetic disease with an autosomal recessive, chronic and progressive character about 10 to 25% of patients develop CF-related diabetes (DRFC). Until now, there is no evidence to support the use of low glycemic index diet to improve glycemic response in pre-diabetic and CF patients. The objective of this study is to evaluate the glycemic improvement after nutritional orientation in patients with cystic fibrosis.

Detailed Description

Cystic fibrosis (CF) is a genetic disease with an autosomal recessive, chronic and progressive character. About 10 to 25% of patients develop CF-related diabetes (DRFC), whose pathogenesis is associated with pancreatic fibrosis and destruction. Until now, there is no evidence to support the use of low glycemic index diet to improve glycemic response in pre-diabetic and CF patients. The objective of this study is to evaluate the glycemic improvement after nutritional orientation in patients with cystic fibrosis in the pre-diabetic phase. Methods: Randomized clinical trial in patients with CF aged over 10 years without hospitalization in the last 4 weeks. Anthropometric measurements, blood pressure, 24 hour recall and food frequency questionnaire will be evaluated. Oral glucose tolerance and glycated hemoglobin test will be dosed at baseline and during 12 weeks of follow-up. The intervention group will receive a nutritional guidance at the beginning of the research.

Registry
clinicaltrials.gov
Start Date
December 12, 2016
End Date
February 20, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • tolerance glucose test values between 100 and 125mg / dl and or glucose 2h after 75g of glucose between 140 and 199 mg / dl
  • Stable pulmonary disease in the last four weeks

Exclusion Criteria

  • Without hospitalization in the last 3 months

Outcomes

Primary Outcomes

glycemic improvement after nutritional orientation in patients with cystic fibrosis in the pre-diabetic phase

Time Frame: 3 months

To evaluate the improvement of glucose levels after the diet intervention. After 12 weeks of intervention will be performed oral glucose tolerance test

Secondary Outcomes

  • To evaluate anthropometric data of the patients before and after the intervention.(3 months)
  • Evaluate the response of forced expiratory volume and forced vital capacity before and after the intervention(3 months)
  • Evaluate the levels of HbA1c before and after the intervention(3 months)

Study Sites (1)

Loading locations...

Similar Trials